In vitro selection of unnatural cyclic peptide libraries via mRNA display.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-61779-379-0_21PMID 22094817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• rtracklayer: an R package for interfacing with genome browsers

  2009cited by this paper
• In vitro selection of protein and peptide libraries using mRNA display.

  2009cited by this paper
• Jalview Version 2—a multiple sequence alignment editor and analysis workbench

  2009cited by this paper
• Ribosomal Synthesis of Cyclic Peptides with a Fluorogenic Oxidative Coupling Reaction

  2009cited by this paper
• Diverse backbone-cyclized peptides via codon reprogramming.

  2009cited by this paper
• Ribosomal synthesis of bicyclic peptides via two orthogonal inter-side-chain reactions.

  2008cited by this paper
• Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides.

  2008cited by this paper
• An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides

  2007cited by this paper
• Enzymatic aminoacylation of tRNA with unnatural amino acids.

  2006cited by this paper
• A highly flexible tRNA acylation method for non-natural polypeptide synthesis

  2006cited by this paper
• Ribosomal synthesis of unnatural peptides.

  2005cited by this paper
• A general route for post-translational cyclization of mRNA display libraries.

  2005cited by this paper
• Transformation of aminoacyl tRNAs for the in vitro selection of "drug-like" molecules.

  2004cited by this paper
• Converting a peptide into a drug: strategies to improve stability and bioavailability.

  2002cited by this paper
• A simplified reconstitution of mRNA-directed peptide synthesis: activity of the epsilon enhancer and an unnatural amino acid.

  2001cited by this paper
• Cell-free translation reconstituted with purified components

  2001cited by this paper
• Psoralen photo-crosslinked mRNA-puromycin conjugates: a novel template for the rapid and facile preparation of mRNA-protein fusions.

  2000cited by this paper
• RNA-peptide fusions for the in vitro selection of peptides and proteins.

  1997cited by this paper
• In vitro virus: Bonding of mRNA bearing puromycin at the 3′‐terminal end to the C‐terminal end of its encoded protein on the ribosome in vitro

  1997cited by this paper
• Ribosomes and protein synthesis : a practical approach

  1990cited by this paper

• Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG)

  2025cites this paper
• EGFRp4 Peptides: A Novel Strategy for Epidermal Growth Factor Receptor (EGFR) Inhibitor

  2025cites this paper
• Zilucoplan: A Newly Approved Macrocyclic Peptide for Treatment of Anti-Acetylcholine Receptor Positive Myasthenia Gravis

  2024cites this paper
• p‐Chloropropynyl Phenylalanine, a Versatile Non‐Canonical Amino Acid for Co‐Translational Peptide Macrocyclization and Side Chain Diversification

  2023cites this paper
• High-Throughput Screening of Natural Product and Synthetic Molecule Libraries for Antibacterial Drug Discovery

  2023cites this paper
• Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation

  2023cites this paper
• Hyperaccurate Ribosomes for Improved Genetic Code Reprogramming.

  2022cites this paper
• Expansion of the genetic code through reassignment of redundant sense codons using fully modified tRNA

  2022cites this paper
• Library and post-translational modifications of peptide-based display systems.

  2021cites this paper
• Modulating Protein–Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples

  2021cites this paper
• Cyclic peptide drugs approved in the last two decades (2001–2021)

  2021cites this paper
• Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics

  2020cites this paper
• Increasing the activity of cell adherent cyclic NGR peptides by optimizing the peptide length and amino acid character

  2020cites this paper
• A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy

  2019cites this paper
• In vitro selection of peptides and proteins - advantages of mRNA display.

  2019cites this paper
• Development of Natural Cyclic Peptide Inhibitors of XRCC4/XLF Interaction for Radio-Sensitization of Breast Tumor Cells

  2018cites this paper
• Highly Constrained Bicyclic Scaffolds for the Discovery of Protease-Stable Peptides via mRNA Display.

  2017cites this paper
• Directed Evolution of Glycopeptides Using mRNA Display.

  2017cites this paper
• Peptide library approach to uncover phosphomimetic inhibitors of the BRCA1 C-terminal domain.

  2015cites this paper
• Development of an in vivo selection system for the identification of antibacterial cyclic peptides

  2015cites this paper
• Peptide and peptide library cyclization via bromomethylbenzene derivatives.

  2015cites this paper
• Targeting tumor invasion: the roles of MDA-9/Syntenin

  2015cites this paper
• Methods for the Creation of Cyclic Peptide Libraries for Use in Lead Discovery

  2015cites this paper
• Directed Evolution of Multivalent Glycopeptides Tightly Recognized by HIV Antibody 2G12

  2014cites this paper
• Selection of a Non-Phosphorylated Peptide Inhibitor of BRCA1’s (BRCT)2 Domain

  2013cites this paper
• mRNA display selection and solid‐phase synthesis of Fc‐binding cyclic peptide affinity ligands

  2013cites this paper
• TRAP display: a high-speed selection method for the generation of functional polypeptides.

  2013cites this paper
• Ribosome display and related technologies : methods and protocols

  2012cites this paper
• BRCA1-directed, enhanced and aberrant homologous recombination

  2012cites this paper